SARS-CoV-2 infection in a fully vaccinated case with newly diagnosed breast cancer: a case report

Abstract

BACKGROUND: the novel Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) was identified in 2019 inWuhan, China, and has not been previously identified in humans. SARS-CoV-2 disease resulted in a global pandemic, impacted on public health service and in major changes in the lifestyle and quality of life of population. CASE: we describe a 62-year-old woman with new diagnosis of breast cancer, infected with the SARS-CoV-2, within 14 days of the second dose of the BNT162b2 mRNA COVID-19 vaccine. CONCLUSION: in cancer population, timely vaccinations and maintenance of the maximum alert threshold, are necessary to prevent infection spreading.